期刊文献+

异体巩膜提上睑肌延长术治疗甲状腺相关眼病上睑退缩 被引量:2

Lengthening of levetor muscle with scleral graft to correct upper eyelidretraction in patients with thyroid-associated-ophthalmopathy
下载PDF
导出
摘要 目的 评估异体巩膜提上睑肌延长术矫正甲状腺相关眼病上睑退缩的临床疗效。方法 对 10例(14眼 )以上睑退缩为主要表现的静止期甲状腺相关眼病患者 ,采用异体巩膜提上睑肌延长术矫正退缩的上睑 ,并观察其临床疗效。结果 术后所有患者睑裂高度均明显下降 ,自觉症状不同程度减轻或消失。术后普遍存在的并发症是眼睑肿胀 ,且持续时间长。在术后 6个月有 2例 2眼出现眼睑退缩复发 ,1例 18眼轻度过矫。结论 异体巩膜提上睑肌延长术能有效矫正甲状腺相关眼病的中重度上睑退缩。 Objective:To evaluate the clinical effect of lengthening of levetor muscle with scleral graft in correcting upper eyelid retraction in patients with inactive thyroid-associated-ophthaimopathy. Methods:10 patients (14 eyelids) with inactive thyroid-associated-ophthalmopathy were recruited. All patients had a typical manifestation of upper eyelid retraction. Results:All patients had subjective improvement in appearance and symptom. We have found eyelid edema to be a common complication of sclera grafts. 1 eye was undercorrected. Recurrent retraction ocurred in 2 eyes in six months after surgery.Conclusions:Lengthening of levetor muscle with scleral graft is effective in correcting upper eyelid retraction.
出处 《中国现代医学杂志》 CAS CSCD 2003年第24期55-58,64,共5页 China Journal of Modern Medicine
关键词 异体巩膜 上睑退缩 甲状腺相关眼病 sclera graft upper eyelid retraction thyroid-associated-ophthalmopathy
  • 相关文献

参考文献5

二级参考文献7

共引文献17

同被引文献25

  • 1张宏文,孙丰源.甲状腺相关眼病及其治疗[J].中国煤炭工业医学杂志,2005,8(1):4-6. 被引量:4
  • 2张向东.提上睑肌-Müller肌延长术治疗眼型Graves病上睑退缩[J].眼科研究,2006,24(2):183-183. 被引量:3
  • 3李冬梅,陈涛,秦毅,王红,赵颖.提上睑肌-Müller肌延长术治疗中、重度上睑退缩[J].临床眼科杂志,2006,14(2):149-151. 被引量:4
  • 4EL-KAISSI S, FRAU MAN AG, WALL JR. Thyroid-associated ophthalmopathy: a practical to classification, natural history and management[J]. Int Med J, 2004, 34(8): 482.
  • 5ECKSTEIN A, QUADBECK B, MUELLER G, et al. Impact of smokingon the response to treatment of thyroid-associated ophthalmopathy[J]. Br J Ophthalmol, 2003, 87(6): 773.
  • 6PERROS P, KENDALL-TAYLOR P. Medical treatment for thyroid-associated ophthal-mopathy [J]. Thyroid, 2002, 12 (3): 241-244.
  • 7BARTALENA L, PINCHERA A. MARCOCCIA. Management of Graves, ophthalmopa-thy: reality and perspectives[J]. Endocrine Reviewsl 2002, 21(2): 168-199.
  • 8vm P, RAGO T, CHIOVATO Let al. Clinical features of patients with Graves disease undergoing remission after antithyroid drug trestment[J]. Thyroid, 1997, 7(3): 369-375.
  • 9MATEJKA G, VERGES B, VAILLANT G, et al. Intravenous methylprednlsolone pulse therapy in the treatment of Graves, ophthalmopathy[J]. Horm Metab Res, 1998, 30(2): 93-98.
  • 10CHANG TC, HUANG KM, HSIAO YL, et al. Relationships of orbital computed tomographic findings and actiyity scores to the prognosis of corticosteroid therapy in patient with Graves' ophthalmopathy[J]. Acta Ophthalmol Stand, 1997, 75(3): 301-304.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部